Endoscopic Submucosal Dissection Market To Witness Revitalization Based On Nanomedicine At A CAGR Of 7.5%

The global Endoscopic Submucosal Dissection Market is expected to grow on an impertinent note in the next 10 years. It could witness a CAGR of 7.5% by 2029. Data processing through Big Data is on the anvil. Clinical software solutions are there to help out, taking the help of Big Data. Thus, data accumulation as well as analytics would be there in a precise manner. This would be the probable facts with healthcare vertical in future.

Endoscopic Submucosal Dissection (ESD) has witnessed slow adoption in Western countries in the past. This is due to the continued referral of patients for surgery or Endoscopic Mucosal Resection (EMR) procedures. Furthermore, ESD demands highly skilled and trained professionals.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22897

Although the procedure is difficult to learn and the training is expensive, a small group of endoscopists in Western countries are becoming more interested. These endoscopists are working toward training in a Japanese centre to learn from experts. This change is expected to increase the adoption rate of endoscopic submucosal dissection over the coming years.

The global endoscopic submucosal dissection market was valued at US$ 200 Mn in 2018, and is expected to exhibit a healthy CAGR of 7.5% over the estimation period (2019-2029).

Company Profiles:

Olympus Corporation
Boston Scientific Corporation
ERBE Elektromedizin GmbH
FUJIFILM Medical Systems U.S.A., Inc
Sumitomo Bakelite Co., Ltd
Ovesco Endoscopy AG
ZEON CORPORATION

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/22897

Key Takeaways of Endoscopic Submucosal Dissection Market Study

ESD is predominantly used for early stomach cancer. This is because the procedure is easy and well-studied for stomach cancer as compared to other gastric cancers. Colorectal cancers are the most complex for ESD procedures, primarily due to the large size of lesions and anatomy of the colon.
Specialty clinics are expected to gain traction with the rising adoption of ESD in the Western hemisphere.

Endoscopic submucosal dissection knives hold nearly 1/3 market share in the endoscopic submucosal dissection market, followed by tissue retractors. The knives segment is expected to continue holding a relatively similar share through 2029.

East Asia, followed by Europe, are the most prominent regions in terms of revenue, due to higher prevalence and adoption of the endoscopic submucosal dissection procedure for gastric cancers.

"Although East Asia will continue to lead the global endoscopic submucosal dissection market, Western countries such as the U.S., Germany, and Brazil, along with the Oceania region, are expected to offer lucrative growth opportunities for players in the endoscopic submucosal dissection market. This is primarily due to rising adoption and increasing skilled professionals in these regions," says a PMR analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/22897

Acquisitions and Partnerships are Key Strategies of Market Players

Manufacturers in the endoscopic submucosal dissection market are focusing on improving their product portfolios though the launch of new products. Key players are working toward getting new products approved by regulatory bodies and launching them at the earliest.

Some manufacturers are also focused toward the development of other strategies, such as setting up training centers to drive product sales and gain market share, globally. Many endoscopists from Western countries opt for such training programs in East Asia to offer ESD procedures in their countries, such as in the U.S., Canada, and Brazil.

More Valuable Insights on Endoscopic Submucosal Dissection Market

Persistence Market Research offers a unique perspective and actionable insights on the endoscopic submucosal dissection market in its latest study, presenting historical demand assessment of 2014-2018 and projections for 2019-2029, on basis of product (knives, tissue retractors, grasps/clips, injection agents, and gastroscopes & colonoscopes), indication (esophageal cancer, stomach cancer, and colon cancer), and end user (hospitals, ambulatory surgical centers, and speciality clinics), across seven major regions.

Access Related Reports-
CAR T-Cell Therapy Market- https://www.persistencemarketresearch.com/market-research/car-t-cell-therapy-market.asp

Cell Culture Media Market- https://www.persistencemarketresearch.com/market-research/cell-culture-media-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.